Pharmacists in Vandalia, Ohio


13 Pharmacists found in Vandalia
female pharmacist

Amy K Bohman, RPH


Pharmacist
780 Northwoods Blvd, Vandalia, OH 45377
937-264-2420     937-264-2484

female pharmacist

Mrs. Deborah Ann Bartone, RPH


Pharmacist
535 S Dixie Dr, Vandalia, OH 45377
937-898-5803     937-898-9340

female pharmacist

Erica Paluf, PHARMD



535 S Dixie Dr, Vandalia, OH 45377
937-889-2121    



male pharmacist

Jeffrey Bartone


Pharmacist
535 S Dixie Dr, Vandalia, OH 45377
937-898-5803    

female pharmacist

Jennifer Crim


Pharmacist
535 S Dixie Dr, Vandalia, OH 45377
937-898-5803    

male pharmacist

Junnan Chen, PHARMACIST


Pharmacist
10 W National Rd, Vandalia, OH 45377
937-898-8829    

male pharmacist

Mr. Mark Edward Stearns, RPH


Pharmacist
10 W National Rd, Vandalia, OH 45377
937-898-8829    

female pharmacist

Nanaama Gyamfi, PHARMD.


Pharmacist
10 W National Rd, Vandalia, OH 45377
937-898-8829    

female pharmacist

Nichole Marie Eckert, RPH


Pharmacist - Clinician (PhC)/ Clinical Pharmacy Specialist
780 Northwoods Blvd, Vandalia, OH 45377
937-264-2420     937-264-2484

female pharmacist

Rheanna Kies


Pharmacist
10 W National Rd, Vandalia, OH 45377
937-898-8829    

male pharmacist

Dr. Ryan Alan Mayer, PHARMD


Pharmacist
780 Northwoods Blvd, Vandalia, OH 45377
937-264-2420     937-264-2484

female pharmacist

Sarah Mcginnis, PHARMD


Pharmacist
10 W National Rd, Vandalia, OH 45377
937-898-8829    

female pharmacist

Dr. Tiffany Marie Oriti, PHARMD


Pharmacist
780 Northwoods Blvd, Vandalia, OH 45377
937-264-2420     937-264-2484


Type of Pharmacists:
Psychiatric Pharmacist: A licensed pharmacist who has demonstrated specialized knowledge and skill in optimizing care of patients with psychiatric illness by assessing and monitoring patients, recognizing drug-induced problems, and recommending appropriate treatment plans.
Oncology Pharmacist: A licensed pharmacist who has demonstrated specialized knowledge and skill in developing, recommending, implementing, monitoring, and modifying pharmacotherapeutic plans to optimize outcomes in patients with malignant diseases.